URVI MEHTA: Open Payments
NPI 1023389491 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 6 payments from 4 companies in 2025. Trend: 2023 $272 · 2024 $448 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $157 |
| Immunocore Limited | 1 | $121 |
| ARRAY BIOPHARMA INC | 1 | $17 |
| Iovance Biotherapeutics, Inc. | 1 | $12 |
Products named: OPDUALAG, KIMMTRAK, BRAFTOVI, Amtagvi.
Industry payments across TX — which companies pay providers there.
